SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sangamo Therapeutics Files SEC Form

Sangamo Therapeutics submits filing to SEC, details not specified

SGMO

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.